期刊
BIOCHEMICAL PHARMACOLOGY
卷 80, 期 12, 页码 1833-1843出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2010.07.021
关键词
Inflammation; Diabetes; Cancer; NF-kappa B; Curcumin; Nutraceuticals; Nanotechnology
资金
- National Institutes of Health [NIH CA-16672, NIH CA-124787-01A2]
- Center for Targeted Therapy at The University of Texas MD Anderson Cancer Center
Extensive research within the last two decades has revealed that most chronic illnesses, including cancer, diabetes, and cardiovascular and pulmonary diseases, are mediated through chronic inflammation. Thus, suppressing chronic inflammation has the potential to delay, prevent, and even treat various chronic diseases, including cancer. Various nutraceuticals from fruits, vegetables, vitamins, spices, legumes, and traditional Chinese and Ayurvedic medicine have been shown to safely suppress proinflammatory pathways; however, their low bioavailability in vivo limits their use in preventing and treating cancer. We describe here the potential of nanotechnology to fill this gap. Several nutraceuticals, including curcumin, green tea polyphenols, coenzyme Q quercetin, thymoquinone and others, have been packaged as nanoparticles and proven to be useful in nanochemoprevention and nanochemotherapy. (C) 2010 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据